ARTICLE | Clinical News
Malaria vaccine: Phase I
December 16, 2002 8:00 AM UTC
RMF Dictagene SA, Lausanne, Switzerland Product: Malaria vaccine Business: Infectious diseases Therapeutic category: Immune stimulation Target: Plasmodium falciparum antigen Description: Synthetic pep...